Table 3.
Eczema Area and Severity Index scores in patients with atopic dermatitis
Eczema Area and Severity Index scorea | Skin area, Median (range)
|
|||
---|---|---|---|---|
Upper extremities | Lower extremities | Trunk | Head and neck | |
Erythemab | ||||
Baseline visit | 1.5 (0–3) | 1.0 (0–3) | 2.0 (0–3) | 1.0 (0–2) |
Final visit | 1.0 (0–2) | 1.0 (0–2) | 1.0 (0–3) | 1.0 (0–2) |
Indurationb | ||||
Baseline visit | 2.0 (0–2) | 1.5 (0–2) | 2.0 (0–3) | 1.0 (0–2) |
Final visit | 1.0 (0–2) | 1.0 (0–2) | 1.0 (0–3) | 1.0 (0–2) |
Excoriationb | ||||
Baseline visit | 1.5 (0–3) | 1.0 (0–3) | 1.5 (0–2) | 1.0 (0–2) |
Final visit | 1.0 (0–2) | 1.0 (0–2) | 1.0 (0–2) | 1.0 (0–2) |
Lichenificationb | ||||
Baseline visit | 2.0 (0–3) | 1.0 (0–3) | 2.0 (0–3) | 1.0 (0–3) |
Final visit | 2.0 (0–3) | 1.0 (0–3) | 2.0 (0–3) | 1.0 (0–3) |
Areac | ||||
Baseline visit | 3.0 (0–6) | 2.0 (0–6) | 2.0 (0–6) | 2.0 (0–5) |
Final visit | 2.5 (0–5) | 2.0 (0–5) | 2.0 (0–5) | 1.0 (0–4) |
Notes:
Baseline visit (n=20), final visit (n=18);
erythema, induration, excoriation, and lichenification were assessed on a four-point scale (half points permitted): 0= none, 1= mild, 2= moderate, 3= severe;
area score is the percentage of skin affected: 0= no atopic dermatitis in this region, 1=1%–9%, 2=10%–29%, 3=30%–49%, 4=50%–69%, 5=70%–89%, 6=90%–100%.